GODREJAGRO NSE filing

Godrej Agrovet Q2 FY27 Results: Profit Declines, Revenue Sees Growth

The RealCase readMedium impact Neutral

Godrej Agrovet reported consolidated revenue of ₹2,995.09 crore for Q2 FY27, an increase from ₹2,563.73 crore YoY. Standalone revenue grew to ₹2,397.08 crore from ₹1,996.83 crore. However, consolidated profit before tax declined to ₹143.24 crore from ₹135.06 crore, while standalone profit before tax decreased to ₹174.92 crore from ₹226.14 crore.

Why it matters

The announcement of quarterly financial results, which include revenue and profit figures, has a direct impact on investor sentiment and stock valuation.

The market read

While revenue showed growth, the profit before tax declined on a standalone and consolidated basis, indicating a mixed financial performance.

Godrej Agrovet Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company's Board of Directors approved these results during a meeting held on November 6, 2026.

For the second quarter of fiscal year 2027, Godrej Agrovet reported a consolidated revenue from operations of ₹2,995.09 crore, an increase from ₹2,563.73 crore in the same period last year. However, the consolidated profit before tax for the quarter stood at ₹143.24 crore, a decrease from ₹135.06 crore in the corresponding quarter of the previous fiscal year.

On a standalone basis, revenue from operations for the quarter was ₹2,397.08 crore, up from ₹1,996.83 crore year-on-year. The standalone profit before tax was ₹174.92 crore, compared to ₹226.14 crore in the prior year's second quarter.

The limited review reports on the unaudited financial results, both standalone and consolidated, were noted by the Board, with an unmodified opinion expressed by the auditors.

Filing to action

What to do with a filing like this

Godrej Agrovet Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Godrej Agrovet Limited. Read the original for the full detail.

View original filing